This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Psimos, Inc., Psirrros Inc.. Active years: 2021-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2025
Title: Sergey Emilevich Kondakov: Innovator in Pharmaceutical Technology
Introduction
Sergey Emilevich Kondakov is a notable inventor based in Moscow, Russia. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of innovative drug delivery systems. With a total of 2 patents, Kondakov's work focuses on enhancing the precision and effectiveness of medication dosing.
Latest Patents
Kondakov's latest patents include a "Finished pharmaceutical form with individual medicine dosing capability (embodiments) and methods of its production and use." This invention outlines a method and system that involves receiving a first quantity of at least one medicine in cartridges of a printing device, dispensing a drop of the medicine onto a porous media, and drying the dispensed drop. Another patent under the same title relates to a new type of finished pharmaceutical form that includes a storage container and a carrier for the medicine. These innovations aim to improve the accuracy of individual medicine dosing.
Career Highlights
Throughout his career, Kondakov has worked with various companies, including Psimos, Inc. and Psirrros Inc. His experience in these organizations has contributed to his expertise in pharmaceutical technology and innovation.
Collaborations
Kondakov has collaborated with notable professionals in his field, including Vladimir Vladimirovich Gordeev and Dmitry Mikhailovich Mikhailov. These collaborations have further enriched his work and expanded the impact of his inventions.
Conclusion
Sergey Emilevich Kondakov stands out as an influential inventor in the realm of pharmaceutical technology. His innovative patents and collaborations reflect his commitment to advancing medical science and improving patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile